95 related articles for article (PubMed ID: 19995245)
1. Reduction of percutaneous absorption of toxic chemicals by dendrimers.
Moghimi HR; Varshochian R; Kobarfard F; Erfan M
Cutan Ocul Toxicol; 2010 Mar; 29(1):34-40. PubMed ID: 19995245
[TBL] [Abstract][Full Text] [Related]
2. Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats.
Lin Y; Fujimori T; Kawaguchi N; Tsujimoto Y; Nishimi M; Dong Z; Katsumi H; Sakane T; Yamamoto A
J Control Release; 2011 Jan; 149(1):21-8. PubMed ID: 20184931
[TBL] [Abstract][Full Text] [Related]
3. Effect of polyamidoamine dendrimer G3 and G4 on skin permeation of 8-methoxypsoralene--in vivo study.
Borowska K; Wołowiec S; Rubaj A; Głowniak K; Sieniawska E; Radej S
Int J Pharm; 2012 Apr; 426(1-2):280-283. PubMed ID: 22310461
[TBL] [Abstract][Full Text] [Related]
4. Transdermal delivery of 8-methoxypsoralene mediated by polyamidoamine dendrimer G2.5 and G3.5--in vitro and in vivo study.
Borowska K; Wołowiec S; Głowniak K; Sieniawska E; Radej S
Int J Pharm; 2012 Oct; 436(1-2):764-70. PubMed ID: 22884834
[TBL] [Abstract][Full Text] [Related]
5. Solubility and in vitro transdermal diffusion of riboflavin assisted by PAMAM dendrimers.
Filipowicz A; Wołowiec S
Int J Pharm; 2011 Apr; 408(1-2):152-6. PubMed ID: 21272625
[TBL] [Abstract][Full Text] [Related]
6. Effects of pressure sensitive adhesives and chemical permeation enhancers on the permeability of fentanyl through excised rat skin.
Mehdizadeh A; Ghahremani MH; Rouini MR; Toliyat T
Acta Pharm; 2006 Jun; 56(2):219-29. PubMed ID: 16613727
[TBL] [Abstract][Full Text] [Related]
7. Effect of poly(amidoamine) (PAMAM) dendrimer on skin permeation of 5-fluorouracil.
Venuganti VV; Perumal OP
Int J Pharm; 2008 Sep; 361(1-2):230-8. PubMed ID: 18582550
[TBL] [Abstract][Full Text] [Related]
8. Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers.
Yiyun C; Tongwen X
Eur J Med Chem; 2005 Nov; 40(11):1188-92. PubMed ID: 16153746
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers.
Cheng Y; Man N; Xu T; Fu R; Wang X; Wang X; Wen L
J Pharm Sci; 2007 Mar; 96(3):595-602. PubMed ID: 17094130
[TBL] [Abstract][Full Text] [Related]
10. Effect of gramicidin on percutaneous permeation of a model drug.
Lee CH; Choi HK
AAPS PharmSciTech; 2000 Jun; 1(2):E13. PubMed ID: 14727846
[TBL] [Abstract][Full Text] [Related]
11. Oleodendrimers: a novel class of multicephalous heterolipids as chemical penetration enhancers for transdermal drug delivery.
Kalhapure RS; Akamanchi KG
Int J Pharm; 2013 Sep; 454(1):158-66. PubMed ID: 23871736
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous absorption of an insect repellent p-menthane-3,8-DIOL: a model for human dermal absorption.
Reifenrath WG; Olson JJ; Vedula U; Osimitz TG
J Toxicol Environ Health A; 2009; 72(13):796-806. PubMed ID: 19557607
[TBL] [Abstract][Full Text] [Related]
13. Synergic enhancing-effect of DEET and dodecylamine on the skin permeation of testosterone from a matrix-type transdermal delivery system.
Zhao H; Choi MK; Kim JS; Yong CS; Choi HG; Chung SJ; Shim CK; Kim DD
Drug Deliv; 2009 Jul; 16(5):249-53. PubMed ID: 19538005
[TBL] [Abstract][Full Text] [Related]
14. Hyperbranched dendritic nano-carriers for topical delivery of dithranol.
Agrawal U; Mehra NK; Gupta U; Jain NK
J Drug Target; 2013 May; 21(5):497-506. PubMed ID: 23594093
[TBL] [Abstract][Full Text] [Related]
15. Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes.
Manosroi A; Khanrin P; Lohcharoenkal W; Werner RG; Götz F; Manosroi W; Manosroi J
Int J Pharm; 2010 Jun; 392(1-2):304-10. PubMed ID: 20381599
[TBL] [Abstract][Full Text] [Related]
16. Transdermal self-permeation enhancement of ibuprofen.
Al-Saidan SM
J Control Release; 2004 Nov; 100(2):199-209. PubMed ID: 15544868
[TBL] [Abstract][Full Text] [Related]
17. Alteration of skin hydration and its barrier function by vehicle and permeation enhancers: a study using TGA, FTIR, TEWL and drug permeation as markers.
Shah DK; Khandavilli S; Panchagnula R
Methods Find Exp Clin Pharmacol; 2008 Sep; 30(7):499-512. PubMed ID: 18985178
[TBL] [Abstract][Full Text] [Related]
18. 3-Hydroxybenzo(a)pyrene as a biomarker of dermal exposure to benzo(a)pyrene.
Payan JP; Lafontaine M; Simon P; Marquet F; Champmartin-Gendre C; Beydon D; Wathier L; Ferrari E
Arch Toxicol; 2009 Sep; 83(9):873-83. PubMed ID: 19526226
[TBL] [Abstract][Full Text] [Related]
19. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration. Studies in hairless rats and human subjects.
Benfeldt E
Acta Derm Venereol Suppl (Stockh); 1999; 206():1-59. PubMed ID: 10605601
[TBL] [Abstract][Full Text] [Related]
20. Effect of PEG6000 on the in vitro and in vivo transdermal permeation of ondansetron hydrochloride from EVA1802 membranes.
Krishnaiah YS; Rama B; Raghumurthy V; Ramanamurthy KV; Satyanarayana V
Pharm Dev Technol; 2009; 14(1):50-61. PubMed ID: 18819031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
